Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hims & Hers
Fierce Healthcare
Hims & Hers stock drops 30% after Novo Nordisk terminates deal
Hims & Hers stock plunged 30% on Monday after Novo Nordisk abruptly ended a collaboration to offer direct access to its weight loss drug Wegovy.
Heather Landi
Jun 23, 2025 12:00pm
Novo inks Wegovy deals with telehealth companies
Apr 29, 2025 11:05am
Eli Lilly makes Zepbound vials cheaper for self-paying patients
Feb 25, 2025 11:35am
Novo Nordisk's semaglutide shortage officially resolved in US
Feb 21, 2025 11:08am
Novo Nordisk calls out dangers of compounded GLP-1s in new ad
Feb 12, 2025 3:39pm
Pfizer wins 2025 Super Bowl with ad's 'likeability': analyst
Feb 11, 2025 7:10am
